Stockreport

Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement [Yahoo! Finance]

Kintara Therapeutics, Inc.  (KTRA) 
PDF therapy for advanced Merkel cell carcinoma in 2H 2024 under FDA's accelerated approval pathway $31 million subscribed financing by TuHURA in connection with the merger [Read more]